Arrowhead Pharmaceuticals
ARWR
#2055
Rank
HK$75.83 B
Marketcap
HK$541.65
Share price
0.30%
Change (1 day)
249.54%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -HK$9.83

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$9.77. In 2024 the company made an earnings per share (EPS) of -HK$39.06 a decrease over its 2023 EPS that were of -HK$14.94.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$9.83-74.83%
2024-HK$39.06161.39%
2023-HK$14.9417.36%
2022-HK$12.7319.85%
2021-HK$10.6361.9%
2020-HK$6.56-216.67%
2019HK$5.63-210.77%
2018-HK$5.0838.3%
2017-HK$3.67-64.93%
2016-HK$10.47-16.25%
2015-HK$12.5028%
2014-HK$9.77-3.85%
2013-HK$10.16-31.58%
2012-HK$14.84331.82%
2011-HK$3.44-51.11%
2010-HK$7.03-79.07%
2009-HK$33.59-37.68%
2008-HK$53.91-16.87%
2007-HK$64.8538.33%
2006-HK$46.88122.22%
2005-HK$21.0942.11%
2004-HK$14.84533.33%
2003-HK$2.34-99.08%
2002-HK$253.6625%
2001-HK$202.9333.33%
2000-HK$152.20-120%
1999HK$760.98-400%
1998-HK$253.66-81.48%
1997-HK$1,370

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$63.05 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.67-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$0.70-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$22.50 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA